Document is current

Any future updates will be listed below

Immunephenotype Predicts Response to Vedolizumab: Integrating Clinical and Biochemical Biomarkers in the Treatment of Inflammatory Bowel Diseases

Crossref DOI link: https://doi.org/10.1007/s10620-018-5039-y

Published Online: 2018-04-02

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark